News and views
May 2012 Br J Cardiol 2012;19:57
ESC issues position paper on new anticoagulants
In a new position paper, the European Society of Cardiology welcomes the new oral anticoagulants for use in atrial fibrillation (J Am Coll Cardiol 2012;59:1413–25)....
May 2012 Br J Cardiol 2012;19:57
ARB number 8 launched in UK
A new angiotensin receptor blocker (ARB), azilsartan medoxomil (Edarbi®, Takeda) has been launched in the UK for the treatment of hypertension. It is the eighth ARB available in the UK and so increases treatment options for hypertensive patients, many of whom are not reaching treatment targets....
May 2012 Br J Cardiol 2012;19:58
Ivabradine receives heart failure licence
Ivabradine (Procoralan®, Servier) has been approved for use in heart failure. The licence has been granted for use in patients in New York Heart Association Class II to IV heart failure with systolic dysfunction, in those in sinus rhythm with a heart rate ≥75 bpm. It should be used in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated....
May 2012 Br J Cardiol 2012;19:59–61
News from the American College of Cardiology Scientific Session 2012
Highlights of the recent American College of Cardiology (ACC) meeting, 24th–27th March 2012, held in Chicago, USA, included a study showing the benefit of CT scans in diagnosing chest pain, more about the role of LDL in the body, and a study raising concern over not treating hypertension in the young....
May 2012 Br J Cardiol 2012;19:62–3
“You want it by when?”
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab… and beyond. In this column, he muses on deadlines upcoming and gone....
May 2012 Br J Cardiol 2012;19:56
Introductory cardiovascular magnetic resonance
Society for Cardiovascular Magnetic Resonance Cardiovascular magnetic resonance (CMR) is playing an increasing role in the diagnosis and classification of heart disease, with as many as one in seven diagnoses changed when scrutinised using CMR. Accordingly, the Cardiology Curriculum requires trainees to observe and report 50 CMR cases, which can be challenging given the current availability of CMR....
May 2012 Br J Cardiol 2012;19:89
Book review
Ultrasound in clinical diagnosis. From pioneering developments in Lund to global application in medicine Editors: Eklöf B, Lindström K, Persson S Publisher: Oxford University Press, Oxford, 2011 ISBN: 978-0-960207-0 Price: £75...
March 2012 Br J Cardiol 2012;19:15
Correspondence: Chest pain
Correspondence from the world of cardiology....
March 2012 Br J Cardiol 2012;19:9
Primary Care Cardiovascular Society announces closure
The British Journal of Cardiology is sorry to report the closure of the Primary Care Cardiovascular Society (PCCS), which ceased operating at on the 31st of January 2012. The BJC has been the society's official journal....
